Showing 20 of 56 recruiting trials for “chordoid-glioma”
RecruitingNCT07236840 ↗
Self-administered Remote Neurological Examination Using Mobile Application in Patients With Brain Tumors
RecruitingNCT07240662 ↗
Vorasidenib in CNS WHO Grade 2 IDH-mutant Diffuse Glioma
RecruitingNCT07405372 ↗
Construction and Application of an IDH Mutation-Targeted PET/MRI Imaging Framework for Precision Diagnosis of Gliomas
Dabrafenib and Trametinib for BRAF V600 Mutant Low-Grade Gliomas
👨⚕️ Sabine Mueller, MD, PHD, University of California, San Francisco📍 4 sites📅 Started Nov 2025View details ↗
A Study of 177Lu-PSMA-617 in People With Gliomas
👨⚕️ Brandon Imber, MD, Memorial Sloan Kettering Cancer Center📍 7 sites📅 Started Oct 2025View details ↗
PrOton Pulsed reduCed dOse Rate Radiotherapy for Recurrent CNS maligNancies Trial
👨⚕️ Robert Press, M.D., Miami Cancer Institute at Baptist Health, Inc.📍 2 sites📅 Started Apr 2025View details ↗
A Study of ERAS-601 in People With Chordoma
👨⚕️ Mrinal Gounder, MD, Memorial Sloan Kettering Cancer Center📍 7 sites📅 Started Apr 2025View details ↗
BC008-1A Injection for Recurrent CNS WHO G4 Glioma
Feasibility of CSF and Plasma ctDNA in BRAF-altered Glioma During Treatment With Plixorafenib
A Study of BL-B01D1 in Patients With Locally Advanced or Metastatic Chordoma
Irinotecan Liposomes Combined With Bevacizumab in the Treatment of Recurrent Glioma
Pembrolizumab and Pemetrexed for Progressive Chordoma
Safety & Efficacy/Tolerability of Rhenium-186 NanoLiposomes (186RNL) for Patients Who Received a Prior 186RNL Treatment
👨⚕️ Andrew J Brenner, PhD, The Cancer Therapy and Research Center at UTHSCSA📍 1 site📅 Started Dec 2024View details ↗
RecruitingNCT06546631 ↗
Investigating Mechanistic Predictors of Interpatient Variability and Temozolomide (TMZ) Induced Haematological Toxicity for Glioma Patients
18F-Fluciclovine PET-MRI in High-grade Glioma
👨⚕️ Mariam Aboian, MD,PhD, Children's Hospital of Philadelphia📍 1 site📅 Started Aug 2024View details ↗
RecruitingNCT06463262 ↗
Exploration of Personalized Biomarkers During Neoadjuvant Radiation Therapy for Spinal and Sacral Chordoma
👨⚕️ Kristin Redmond, MD, MPH, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins📍 2 sites📅 Started Jun 2024View details ↗
RecruitingNCT06180434 ↗
Short Term Outcomes After PRoton and PhotoN RadiOtherapy for IDH Mutated Grade 2 and 3 Gliomas
👨⚕️ Alejandra Mendez Romero, MD PhD, Assitant Professor, Radiation Oncologist📍 1 site📅 Started May 2024View details ↗
Effect of Electroacupuncture Combined With Paclitaxel Clinical Efficacy of Patients With Recurrence of High-grade Glioma
🏥 The Third Affiliated hospital of Zhejiang Chinese Medical University📍 1 site📅 Started Apr 2024View details ↗
Personalized Rendering of Motor System Functional Plasticity Potential to Improve Glioma Resection and Quality of Life
RecruitingNCT06036381 ↗
Spatial and Temporal Characterization of Gliomas Using Radiomic Analysis
Page 1 of 3Next →
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →